Delpharm
Saint-Rémy, France
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (10)
○ EMA GMP
○ MHRA GMP
Quick Facts: Delpharm
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Saint-Rémy, France
- Modalities
- Sterile Injectables (liquid, lyophilized, prefilled syringe), Oral Solid Dose (tablets, capsules, pellets), Semi-Solids (creams, gels, ointments), Non-Sterile Liquids (solutions, suspensions, nasal sprays), Biologics / Biotech Drug Product, APIs, Clinical Manufacturing, Fill-Finish
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Delpharm
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesSterile Injectables (liquid, lyophilized, prefilled syringe), Oral Solid Dose (tablets, capsules, pellets), Semi-Solids (creams, gels, ointments), Non-Sterile Liquids (solutions, suspensions, nasal sprays), Biologics / Biotech Drug Product, APIs, Clinical Manufacturing, Fill-Finish
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (8 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press10 articles
Broad modality coverage (8 modalities)
Recent News 10 articles
CDMO Delpharm gets cash infusion from Canada to help modernize former Sandoz injectables plant - Fierce Pharma
CDMO Famar expands reach in Europe with acquisition of sterile manufacturing plant in Germany - Fierce Pharma
Delpharm Acquires Leiden Development Center from Dr. Reddy’s - Contract Pharma
Delpharm to Modernize Its Injectable Manufacturing Facility in Boucherville - Contract Pharma
Delpharm to Manufacture Pfizer/BioNTech mRNA Vax in France - Contract Pharma
GSK to Sell Poznań Manufacturing Site to Delpharm - Contract Pharma
The CDMO/CMO Report: Parenteral Drugs - DCAT Value Chain Insights
The CDMO/CMO Report: Injectable Drugs - DCAT Value Chain Insights
Astellas sells Netherlands manufacturing plant to CDMO Delpharm - Fierce Pharma
GlaxoSmithKline offloads Polish plant with 700 workers to French CDMO Delpharm - Fierce Pharma
Frequently Asked Questions About Delpharm
What is Delpharm's CDMO Signal Score?
Delpharm has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Delpharm for a manufacturing program?
Use the free AI matchmaker to compare Delpharm against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Catalent
Bagsværd, Denmark (operating under Novo Holdings)
Signal Score: 76.5
Monoclonal Antibody, Recombinant Protein, ADC, AAV, mRNA, Plasmid DNA, Fill-Finish
Catalent (Novo Holdings)
Harmans, MD · Gosselies, BE
Signal Score: 75.1
Monoclonal Antibody, Recombinant Protein, ADC, AAV, mRNA, Plasmid DNA, Fill-Finish
Vetter Pharma International GmbH
Ravensburg, Germany
Sterile Fill-Finish (syringes, vials, cartridges), Aseptic Injectable Manufacturing, Clinical Manufacturing, Commercial Filling, Drug Product Development, Assembly & Secondary Packaging, Prefilled Drug-Delivery Systems, Oligonucleotides (fill-finish), Monoclonal Antibodies (fill-finish), Biologics Injectables
AsymBio
Shanghai, China
Monoclonal Antibody, Bispecific Antibody, Recombinant Protein, ADC, Bioconjugates (NDC, RDC, AOC, PDC, BsADC), Plasmid DNA, mRNA, Fill-Finish
Advanced BioScience Laboratories, Inc. (ABL Inc.)
Rockville, MD
AAV, Lentiviral, Adenoviral, HSV-1, Vaccinia/MVA, Oncolytic Virus, Viral Vaccines, Recombinant Proteins, Cell Banking, Fill-Finish